XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense related to restricted stock units (“RSUs”), stock options, and Employee Stock Purchase Plan (“ESPP”) shares, which was allocated as follows (amounts in thousands):
Three Months Ended December 31,
 20242023
Cost of revenue$161 $129 
Selling and marketing974 820 
Research and development1,124 1,041 
General and administrative2,206 1,440 
Stock-based compensation expense
$4,465 $3,430 
Schedule of Stock Option Activity
The following table summarizes stock option activity under the Company’s equity plans during the three months ended December 31, 2024:
Number of
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Term
(in years)
Aggregate Intrinsic Value
(in thousands)
Outstanding at September 30, 2024461,710 $8.00 2.7$1,183 
Granted— — 
Exercised(66,200)2.68 410 
Canceled— — 
Outstanding at December 31, 2024395,510 8.89 2.9886 
Vested and Expected to Vest at December 31, 2024395,510 8.89 2.9886 
Exercisable at December 31, 2024395,510 8.89 2.9886 
Schedule of RSU Activity
The following table summarizes RSU activity under the Company’s equity plans during the three months ended December 31, 2024:
 
Number of
Shares
Weighted-Average
Fair Market Value
Per Share
Outstanding at September 30, 20242,453,630 $11.25 
Granted1,207,580 8.99 
Settled(529,048)11.84 
Canceled(79,420)11.72 
Outstanding at December 31, 20243,052,742 10.24 
Schedule of Performance RSU Activity
The following table summarizes Performance RSU activity under the Company’s equity plans during the three months ended December 31, 2024:
 
Number of
Shares
Weighted-Average
Fair Market Value
Per Share
Outstanding at September 30, 2024699,458 $12.82 
Granted1,175,404 8.70 
Settled— — 
Canceled(78,810)16.95 
Outstanding at December 31, 20241,796,052 9.88